GPP
EGRX

Great Point Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Great Point Partners’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-548,290
Closed -$21.3M – 47
2016
Q2 		$21.3M Buy
+548,290
New +$21.3M 6.09% 8